EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breast Cancer Information Grand Round for Survivorship (BIG-S) prospective cohort

Danbee Kang, Juwon Park, Hyunsoo Kim, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jai Min Ryu, Juhee Cho, Se Kyung Lee

European Journal of Epidemiology · 2025

DOI: 10.1007/s10654-025-01262-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Epidemiology, 2025. Verfasst von Danbee Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Quality of Life, Cancer Survivors, Survivorship. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sungkyunkwan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing evidence indicates that long-term effects of breast cancer treatment can significantly impact survivors’ ability to fulfill their personal, familial, and social roles. However, few studies comprehensively integrate patient-reported outcomes (PROs) and real-world healthcare utilization data, particularly in Asian populations. Thus, we established a prospective cohort, the Breast Cancer Information Grand Round for Survivorship (BIG-S), to address these gaps and introduce this resource. The prospective BIG-S cohort recruited patients newly diagnosed with breast cancer at Samsung Medical Center starting in November 2018. Clinical data, recurrence, and healthcare utilization were systematically collected from electronic medical records by trained researchers, and body composition was measured using multifrequency bioelectrical impedance analysis. PROs were assessed following recommendations from the International Consortium for Health Outcomes Measurement (ICHOM). These included health-related quality of life, physical, psychological, social, and cognitive functions, symptoms, healthy behaviors, financial difficulty, spiritual well-being, and cancer adaptation, using validated questionnaires. A total of 2,749 patients participated, with an average age of 49.7 years. The mean quality-of-life score at diagnosis was 55.6, indicating moderate general well-being, and improved gradually to 68.2 at four years post-diagnosis. At baseline, participants showed high physical, cognitive, and role functioning scores but had relatively lower emotional and social functioning scores. Over four years, emotional and social functioning improved, whereas cognitive and role functioning declined. Survivors initially reported low sexual functioning, sexual enjoyment, and future perspectives, all of which significantly decreased during follow-up. Fatigue and insomnia were persistent throughout the observation period. Healthcare utilization initially concentrated on plastic surgery and rehabilitation medicine and increasingly shifted towards gynecology, family medicine, and psychiatry after two years. The BIG-S cohort uniquely integrates clinical data, PROs, and healthcare utilization patterns, offering comprehensive insights into breast cancer survivorship trajectories. Findings from BIG-S are expected to guide targeted interventions and inform tailored survivorship care strategies, especially for Asian breast cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsQuality of LifeCancer SurvivorsSurvivorshipPatient Acceptance of Health CareHumansFemaleMiddle AgedProspective StudiesPatient Reported Outcome MeasuresAdultAged

Stichwörter der Autor:innen

Breast cancerProspective cohortQuality of lifeSurvivorship

Autor:innen und Institutionen

  • Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
  • Trend Sensing and Risk Modeling Center, Institution of Quality of Life in Cancer, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. jcho@skku.edu.
  • Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea. jcho@skku.edu.

Förderung

  • Sungkyunkwan University

Zitieren

APA

Kang, D., Park, J., Kim, H., Lee, J. E., Nam, S. J., Kim, S. W., Yu, J., Chae, B. J., Ryu, J. M., Cho, J., & Lee, S. K. (2025). Breast Cancer Information Grand Round for Survivorship (BIG-S) prospective cohort. European Journal of Epidemiology. https://doi.org/10.1007/s10654-025-01262-5

Vancouver

Kang D, Park J, Kim H, Lee JE, Nam SJ, Kim SW, et al. Breast Cancer Information Grand Round for Survivorship (BIG-S) prospective cohort. European Journal of Epidemiology. 2025. doi:10.1007/s10654-025-01262-5

BibTeX
@article{Kang2025,
  author = {Kang, Danbee and Park, Juwon and Kim, Hyunsoo and Lee, Jeong Eon and Nam, Seok Jin and Kim, Seok Won and Yu, Jonghan and Chae, Byung Joo and Ryu, Jai Min and Cho, Juhee and Lee, Se Kyung},
  title = {Breast Cancer Information Grand Round for Survivorship (BIG-S) prospective cohort},
  journal = {European Journal of Epidemiology},
  year = {2025},
  doi = {10.1007/s10654-025-01262-5}
}
Kostenlos starten →